These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8580273)
1. Erythromycin shortens orocaecal transit time in diabetic male subjects: a double-blind placebo-controlled study. Minocha A; Katragadda R; Rahal PS; Ries A Aliment Pharmacol Ther; 1995 Oct; 9(5):529-33. PubMed ID: 8580273 [TBL] [Abstract][Full Text] [Related]
2. Effects of oral erythromycin on fasting and postprandial antroduodenal motility in patients with type I diabetes, measured with an ambulatory manometric technique. Samsom M; Jebbink RJ; Akkermans LM; Bravenboer B; vanBerge-Henegouwen GP; Smout AJ Diabetes Care; 1997 Feb; 20(2):129-34. PubMed ID: 9118759 [TBL] [Abstract][Full Text] [Related]
3. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers. Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468 [TBL] [Abstract][Full Text] [Related]
4. Orocaecal transit, bacterial overgrowth and hydrogen production in diabetes mellitus. Sarno S; Erasmas LP; Haslbeck M; Hölzl R Ital J Gastroenterol; 1993; 25(9):490-6. PubMed ID: 8123897 [TBL] [Abstract][Full Text] [Related]
5. Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: a double-blind, randomized, placebo-controlled study. Dive A; Miesse C; Galanti L; Jamart J; Evrard P; Gonzalez M; Installé E Crit Care Med; 1995 Aug; 23(8):1356-62. PubMed ID: 7634805 [TBL] [Abstract][Full Text] [Related]
6. Comparison of orocaecal transit times assessed by the lactulose/breath hydrogen and the sulphasalazine/sulphapyridine methods. Staniforth DH Gut; 1989 Jul; 30(7):978-82. PubMed ID: 2569435 [TBL] [Abstract][Full Text] [Related]
7. Effect of erythromycin on the oro-caecal transit time in man. Lehtola J; Jauhonen P; Kesäniemi A; Wikberg R; Gordin A Eur J Clin Pharmacol; 1990; 39(6):555-8. PubMed ID: 2095341 [TBL] [Abstract][Full Text] [Related]
8. Effects of low doses of erythromycin on the 13C Spirulina platensis gastric emptying breath test and electrogastrogram: a controlled study in healthy volunteers. DiBaise JK; Park FL; Lyden E; Brand RE; Brand RM Am J Gastroenterol; 2001 Jul; 96(7):2041-50. PubMed ID: 11467630 [TBL] [Abstract][Full Text] [Related]
9. [Measurement of the orocaecal transit time after an oral lactulose load--does the fasting breath hydrogen concentration affect the feasibility of the test?]. Jonderko K; Janikowska A; Kasicka-Jonderko A; Kotuła I; Błońska-Fajfrowska B Wiad Lek; 2008; 61(4-6):107-12. PubMed ID: 18939360 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of lactulose plus 13C-acetate breath test in the diagnosis of gastrointestinal motility disorders. Urita Y; Hike K; Torii N; Kikuchi Y; Sasajima M; Miki K J Gastroenterol; 2002; 37(6):442-8. PubMed ID: 12108678 [TBL] [Abstract][Full Text] [Related]
11. Erythromycin as a prokinetic agent in preterm infants. Costalos C; Gounaris A; Varhalama E; Kokori F; Alexiou N; Kolovou E J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):23-5. PubMed ID: 11753159 [TBL] [Abstract][Full Text] [Related]
12. Oral or intravenous erythromycin has no effect on human distal colonic motility. Jameson JS; Rogers J; Misiewicz JJ; Raimundo AH; Henry MM Aliment Pharmacol Ther; 1992 Oct; 6(5):589-95. PubMed ID: 1420750 [TBL] [Abstract][Full Text] [Related]
13. Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: lactulose accelerates small bowel transit. Miller MA; Parkman HP; Urbain JL; Brown KL; Donahue DJ; Knight LC; Maurer AH; Fisher RS Dig Dis Sci; 1997 Jan; 42(1):10-8. PubMed ID: 9009110 [TBL] [Abstract][Full Text] [Related]
14. Oral erythromycin improves gastrointestinal motility and transit after subtotal but not total gastrectomy for cancer. Altomare DF; Rubini D; Pilot MA; Farese S; Rubini G; Rinaldi M; Memeo V; D'Addabbo A Br J Surg; 1997 Jul; 84(7):1017-21. PubMed ID: 9240156 [TBL] [Abstract][Full Text] [Related]
15. Assessment of orocaecal transit time in different localization of Crohn's disease and its possible influence on clinical response to therapy. Tursi A; Brandimarte G; Giorgetti G; Nasi G Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):69-74. PubMed ID: 12544697 [TBL] [Abstract][Full Text] [Related]
16. Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients. Gonlachanvit S; Hsu CW; Boden GH; Knight LC; Maurer AH; Fisher RS; Parkman HP Dig Dis Sci; 2003 Mar; 48(3):488-97. PubMed ID: 12757160 [TBL] [Abstract][Full Text] [Related]
17. Effects of oral erythromycin on upper gastrointestinal motility in patients with non-insulin-dependent diabetes mellitus. Kao CH; Wang SJ; Pang DY Nucl Med Commun; 1995 Sep; 16(9):790-3. PubMed ID: 7478413 [TBL] [Abstract][Full Text] [Related]
18. Inulin is an ideal substrate for a hydrogen breath test to measure the orocaecal transit time. Geboes KP; Luypaerts A; Rutgeerts P; Verbeke K Aliment Pharmacol Ther; 2003 Oct; 18(7):721-9. PubMed ID: 14510746 [TBL] [Abstract][Full Text] [Related]